✦ LIBER ✦

Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase

✍ Scribed by Jabbour, E.; Kantarjian, H. M.; Abruzzo, L. V.; O'Brien, S.; Garcia-Manero, G.; Verstovsek, S.; Shan, J.; Rios, M. B.; Cortes, J.

Book ID: 121733711
Publisher: American Society of Hematology
Year: 2007
Tongue: English
Weight: 117 KB
Volume: 110
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2007-01-070045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P107 Chromosomal abnormalities in Philad

P107 Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase

✍ S. Jootar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

6/155), high white cell number (13/155) (red cell unit) or low thrombocyte number (14/125) (thrombocyte unit). Summary: Donors with low hemoglobin levels have to be excluded from the blood donation service for 3 months. So, in theory haemoglobin concentration of all total blood units is suitable for

Chromosomal abnormalities in Philadelphi

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

✍ Jorge Medina; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract ## BACKGROUND Anecdotal cases of chromosomal abnormalities in Philadelphia chromosome (Ph)‐negative metaphases have been reported in patients with chronic myelogenous leukemia (CML) in the chronic phase during treatment with interferon and, more recently, with imatinib. This phenomenon

The long-term clinical implications of c

The long-term clinical implications of clonal chromosomal abnormalities in newly diagnosed chronic phase chronic myeloid leukemia patients treated with imatinib mesylate

✍ Sung-Eun Lee; Soo Young Choi; Ju-Hee Bang; Soo-Hyun Kim; Eun-jung Jang; Ji-Young 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 436 KB

Clonal chromosomal abnormalities in the

Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib

✍ Guilbert-Douet, N; Morel, F; Bris, M-J Le; Berthou, C; Morice, P; Bourquard, P; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB

Imatinib in patients with newly diagnose

Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia

✍ Stephen G. O'Brien; Michael W.N. Deininger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Imatinib mesylate therapy improves survi

Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase : Comparison with historic data

✍ Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Francis J. Giles; Mary Beth Ri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract ## BACKGROUND The International Randomized study of Interferon‐alpha plus cytarabine (IFN‐α plus ara‐C) versus STI571 (imatinib mesylate) [IRIS trial] in patients with newly diagnosed Philadelphia chromosome (Ph)‐positive, chronic‐phase chronic myelogenous leukemia (CML) has not shown